Back to Search Start Over

IL-17-induced inflammation modulates the mPGES-1/PPAR-γ pathway in monocytes/macrophages.

Authors :
Raucci, Federica
Saviano, Anella
Casillo, Gian Marco
Guerra‐Rodriguez, Miguel
Mansour, Adel Abo
Piccolo, Marialuisa
Ferraro, Maria Grazia
Panza, Elisabetta
Vellecco, Valentina
Irace, Carlo
Caso, Francesco
Scarpa, Raffaele
Mascolo, Nicola
Alfaifi, Mohammed
Iqbal, Asif Jilani
Maione, Francesco
Guerra-Rodriguez, Miguel
Source :
British Journal of Pharmacology; May2022, Vol. 179 Issue 9, p1857-1873, 17p, 1 Chart, 7 Graphs
Publication Year :
2022

Abstract

<bold>Background and Purpose: </bold>Recent biochemical and pharmacological studies have reported that in several tissues and cell types, microsomal PGE2 synthase (mPGES) and PPAR-γ expression are modulated by a variety of inflammatory factors and stimuli. Considering that very little is known about the biological effects promoted by IL-17 in the context of mPGES-1/PPAR-γ modulation, we sought to investigate the contribution of this unique cytokine on this integrated pathway during the onset of inflammation.<bold>Experimental Approach: </bold>We evaluated effects of PF 9184 (mPGES-1 inhibitor) and troglitazone (PPAR-γ agonist) in vitro, using the mouse macrophage cell line J774A.1. In vivo, the dorsal air pouch model in CD1 mice was used, and inflammatory infiltrates were analysed by flow cytometry. Locally produced cyto-chemokines and PGs were assessed using elisa assays. Western blots were also employed to determine the activity of various enzymes involved in downstream signalling pathways.<bold>Key Results: </bold>PF 9184 and troglitazone, in a time- and dose-dependent manner, modulated leukocyte infiltration, myeloperoxidase activity, and the expression of COX-2/mPGES-1, NF-кB/IкB-α, and mPTGDS-1/PPAR-γ, induced by IL-17. Moreover, both PF 9184 and troglitazone modulated PG (PGE2 , PGD2 , and PGJ2 ) production, the expression of different pro-inflammatory cyto-chemokines, and the recruitment of inflammatory monocytes, in response to IL-17.<bold>Conclusions and Implications: </bold>Our data suggest that IL-17 may constitute a specific modulator of inflammatory monocytes during later phases of the inflammatory response. The results of this study show, for the first time, that the IL-17/mPGES-1/PPAR-γ pathway could represent a potential therapeutic target for inflammatory-based and immune-mediated diseases.<bold>Linked Articles: </bold>This article is part of a themed issue on Inflammation, Repair and Ageing. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.9/issuetoc. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00071188
Volume :
179
Issue :
9
Database :
Complementary Index
Journal :
British Journal of Pharmacology
Publication Type :
Academic Journal
Accession number :
156112887
Full Text :
https://doi.org/10.1111/bph.15413